Tweets by @cellcentric

Delighted to announce $33m of further funding; continuing to progress our first-in-class p300/CBP inhibitor CCS1477, in clinical trials for multiple cancer applications. pic.twitter.com/pzxlzz2mmd

Neil and Nigel (virtually) at the always excellent Prostate Cancer Foundation Retreat over the next 3 days. pic.twitter.com/NjVknIyWW0

Great to have another site open as we expand clinical testing of our first-in-class p300/CBP inhibitor. Edinburgh; haem malignancies. pic.twitter.com/HfC6vJsy4A

Fabulous to have Tahira joining the team, as CellCentric looks to expand its clinical trials of CCS1477, including into Europe in 2021. pic.twitter.com/G7EGI9F3ED

Another site active; CellCentric’s CCS1477 haematology clinical programme. Many thanks to Paresh Vyas and the team at Oxford. pic.twitter.com/eeiFw5nMDK

CellCentric one of the ambassador co’s for UK biotech sector today at Parliament. Turning world leading research into novel healthcare products. @BIA_UK pic.twitter.com/D7wooMQobQ